Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes used to connect prosthetic limbs to the nervous system.
Researchers chemically modified the surface of polyimide electrodes to enable a slow release of the drug at the implant site over two months. Animal testing confirmed the method significantly reduced inflammation while preserving biocompatibility, offering a breakthrough for chronic neuroprosthetic use.
Key Facts:
- Drug Coating Innovation: Dexamethasone was covalently bound to the electrode surface for sustained local release.
- Reduced Immune Reaction: The coating lowered inflammation and scar tissue in preclinical models.
- Improved Stability: Implants maintained biocompatibility and mechanical function over critical early months.
Source: UAB
An international research team, including scientists from the Institut de Neurociències at the Universitat Autònoma de Barcelona (UAB), has developed a new solution to reduce the immune response triggered by neural prosthetics used after limb amputations or severe nerve injuries.
The approach consists of coating the electronic implants (which connect the prosthetic device to the patient’s nervous system) with a potent anti-inflammatory drug. This coating helps the body better tolerate the implant, improving its long-term performance and stability.
Neural electrode implants are commonly used in prosthetics to restore communication between the device and the nervous system.
However, their long-term effectiveness can be compromised by the body’s natural immune reaction to foreign objects, which leads to the formation of scar tissue around the implant and can impair its function.
Now, a recent study published in Advanced Healthcare Materials by researchers from the Universitat Autònoma de Barcelona, the Università di Ferrara, the University of Freiburg, and Chalmers University of Technology, conducted as part of the European collaborative project BioFINE, reports a novel method to improve the biocompatibility and chronic stability of these electrodes.
The technique involves activating and modifying the surface of polyimide (a material commonly used for implanted electrodes) using a chemical strategy that enables the covalent binding of the anti-inflammatory drug dexamethasone.
This innovation allows the drug to be released at the implant site slowly over at least two months, a critical period when the immune system typically mounts its strongest response.
Biological tests showed that this approach reduces inflammation-related signals in immune cells, while maintaining the material’s biocompatibility and mechanical integrity.
Animal testing further confirmed that the dexamethasone-releasing implants significantly reduce immune reactions and scar tissue formation around the device.
These findings suggest that the slow and localized release of dexamethasone from the implant surface could extend the functional lifespan of neural prostheses, offering a promising step forward in addressing the long-term challenges of implantable neurotechnology.
“This is a main step that has to be complemented by the demonstration in vivo that this coating improves the functional performance of chronically implanted electrodes in the peripheral nerves, for stimulating and recording nerve signals”, says Dr. Xavier Navarro, principal investigator of the UAB team in the BioFINE project.
News
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
